The relaxation responses to corticotropin-releasing factor in rat aorta are endothelium dependent and gestationally regulated

American Journal of Obstetrics and Gynecology

Volumn 176, Issue 1 I, 1997, Pages 234-240

  Jain, Venu ^a   Vedernikov, Yurij P ^a   Saade, George R ^a   Chwalisz, Kristof ^a   Garfield, Robert E ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Corticotropin releasing factor; Endothelium; Pregnancy; Rat aorta; Vascular smooth muscle

Indexed keywords

CORTICOTROPIN RELEASING FACTOR;

ANIMAL; AORTA; ARTICLE; BREEDING; FEMALE; MUSCLE RELAXATION; PHYSIOLOGY; PREGNANCY; RAT; SPRAGUE DAWLEY RAT; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA; CORTICOTROPIN-RELEASING HORMONE; ENDOTHELIUM, VASCULAR; FEMALE; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; PREGNANCY; PREGNANCY, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030641038     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(97)80042-7     Document Type: Article

References (25)

1. Jours MT, Gillham B, Mulhouse EW. The nature of corlicotropin releasing (actor from rat hypothalamus in vitro. Fed Proc 1977;36:2104-9.
2. Rivier C, Brownstein M, Spiess J, Rivier J, Vale W. In vivo corticotropiu-releasing factor-induced secretion of adrenocorticolropin, beta-eudorphiii and corticosterone. Endocrinology 1982;110:272-8.
3. Brown MR, Fisher JA, Spiess J, Rivier J, Rivier C, Vale W. Comparison of biologic actions of corticotropin-releasing factor and sauvagine. Regul Pept 1982;4:107-14.
4. Fisher LA, Jesseu G, Brown MR. Corticotropin-releasing factor (CRF): mechanisms to elevate arterial pressure and heart rate. Regul Pept 1983;5:153-161.
5. Gardiner SM, Compton AM, Bennet T. Regional haemodynamic effects of depressor ueuropeptides in conscious, unrestrained, Long Evans and Brattleboro rats. Br J Pharmacol 1988:95:197-208.
6. Pralong FP, Corder R, Gaillard RC. Responses of the pituitary-adrenal axis to infusions of corticotropin-releasing factor, vasoactive intestinal peptide and other depressor agents. Regul Pept 1991:32:217-26.
7. Corder R, Turnill D, Ling N, Gaillard RC. Attenuation of corticotropin-releasing factor-induced hypotension in anesthetized rats with the CRF antagonist, a-helical CRF 9-41; comparison with effect on ACTH release. Peptides 1992:13:1-6.
8. Lei S, Richter R, Bienen M, Mulvany MJ. Relaxing actions of corticotropin-releasing factor on rat resistance arteries. Br J Pharmacol 1993;108:941-7.
9. 125I] Tyr-corticotropin-releasing factor to rabbit aorta is reduced by removal of the endothelium. EurJ Pharmacol 1987;135: 111-2.
10. Campbell EA, Linton EA, Wolfe CD, Scraggs PR, [ones MT, Lowry PJ. Plasma corticotropin-releasing hormone concentrations during pregnancy and parturition. J Clin Endocrinol Metab 1987;64:1054-9.
11. Sasaki A, Shinkawa O, Margioris AN, Liotta AS, Sato S, Murakami O, et al. Immunoreactive corticotropin-releasing hormone in human plasma during pregnancy, labor and delivery. J Clin Endocrmol Metab 1987:64:224-9.
12. Frini DM, Emanuel RL, Robinson BG, Smas CM, Asler GK, Majzoub JA. Characterization and gestational regulation of corticotropin-releasing hormone messenger RNA in human placenta. J Clin Invest 1988;82:287-92.
13. Rilev SC, Wallon JC, Herlick JM, Challis JR. The localization and distribution of corticotropin-releasing hormone in the human placenta and fetal membranes throughout gestation. J Clin Endocrinol Metab 1991;72:1001-7.
14. Poston L, McCarthy AL, Ritter JM. Control of vascular resistance in the maternal and feto-placental arterial beds. Pharmacol Ther 1995;65:215-39.
15. Inagami T, Naruse M, Hoover R. Endothelium as an endocrine organ. Annu Rev Physiol 1995;57:171-89.
16. Tare VI, Parkington HC, Coleinan HA, Neild TO. Hyperpolarization and relaxation of the arterial smooth muscle caused by nitric oxide derived from the endothelium. Nature 1990;346:69-71.
17. Clifton VL, Read MA, Leitch IM, Giles WB, Boura ALA, Robinson PJ, et al. Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation: involvement of the nitric oxide-cyclic guanosine 3′,5′-monophosphate-mediated pathway. J Clin Endocrinol Metab 1995;80:2888-93.
18. 2+ channels in human epidermoid A-431 cells. EurJ Pharmacol 1994;267:135-42.
19. Schini-Kerth VB, Vanhoutte P.M. Nitric oxide synthases in vascular cells. Exp Physiol 1995:80:885-905.
20. Lüscber TF, Tanner EC. Endothelial regulation of vascular tone and growth. Am J Hypertens 1993;6:283S-93S.
21. Tropper PJ, Warren WB, Jozak SM, Conwell IM, Stark Rl, C.oland RS. Corticotropin releasing hormone concentrations in umbilical cord blood of preterm fetuses. J Dev Physiol 1992:18:81-5.
22. Giles WB, McEean M, Davies JJ, Smith R. Abnormal umbilical arten,' Doppier waveforms and cord blood corticotropinreleasing hormone. Obstet Gynecol 1996:87:107-11.
23. Clifton VL, Read MA, Eeitch IM, Boura AIA Robinson PJ. Smith R. Corticotropin-releasing hormone induced vasodilation in the human fetal placental circulation. J Clin Endocrinol Metab 1994:79:666-9.
24. Friedman SA, Eubarsky SI., Ahokas RA, Nova A, Sibai, BM. Preeclampsia and related disorders: clinical aspects and relevance of endothelin and nitric oxide. Clin Perinatol 1995:22:343-55.
25. Yallampalli C, Garfield RE. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol 1993;169:1316-20.